계명대학교 의학도서관 Repository

레보플록사신 제제인 제일크라비트정에 대한 레보록신정의 생물학적동등성시험

Metadata Downloads
Author(s)
김수경권지윤
Keimyung Author(s)
Kim, Soo Kyung
Department
Dept. of Pharmacology (약리학)
Journal Title
Keimyung Medical Journal
Issued Date
2009
Volume
28
Issue
1
Keyword
Jeil Cravit J.IC®Levoloxin®
Abstract
This study was conducted to evaluate the bioequivalence of two levofloxacin formulations, Jeil Cravit J.IC® tablet (Jeil Pharm. Co., Ltd. Korea, reference drug) and Levoloxin® tablet (Korea United Pharm Inc., Korea, test drug), according to the guidelines of Korea Food and Drug Administration (KFDA). Twenty-six healthy Korean volunteers employed a randomized, 2 × 2 crossover study with a one-week washout period. The two products were administered in 2 tablets (200 mg of levofloxacin) as single oral dose for this study. After dosing, serial blood samples were collected for a period of 24 hours. Plasma levofloxacin concentrations were
measured by using high performance liquid chromatography (HPLC) and UV detector. The pharmacokinetic parameters including area under the concentration from time zero to 24 hr (AUCt), maximum plasma drug concentration (Cmax), and time to reach Cmax (Tmax) were obtained from plasma concentration data of each time. Analysis of variance (ANOVA) test was utilized for the statistical analysis of parameters using logarithmically transformed AUCt and Cmax. Mean ratio of AUCt and Cmax of Levoloxin® tablet were 0.991 (90% confidence interval: 0.9484 ≤ δ≤ 1.0360) and 1.06 (90% confidence interval: 0.9899 ≤ δ≤ 1.1366) compared to those of Jeil Cravit J.IC® tablet respectively. Mean Tmax of Levoloxin® tablet was 1.008 ± 0.419 hr and that of Jeil Cravit J.IC® tablet was 1.187 ± 0.749 hr. These results satisfied the bioequivalence criteria of KFDA guidelines in AUCt and Cmax, In all of these results, we concluded that Levoloxin® tablet was to be bioequivalent to Cravit J.IC® tablet in terms of bioavailability.
Alternative Title
Bioequivalence Study of Two Levofloxacin Formulations, Levoloxin® Tablet to Jeil Cravit® Tablet
Keimyung Author(s)(Kor)
김수경
Publisher
Keimyung University School of Medicine
Citation
김수경 and 권지윤. (2009). 레보플록사신 제제인 제일크라비트정에 대한 레보록신정의 생물학적동등성시험. Keimyung Medical Journal, 28(1), 27–34.
Type
Article
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/15424
Appears in Collections:
2. Keimyung Medical Journal (계명의대 학술지) > 2009
1. School of Medicine (의과대학) > Dept. of Pharmacology (약리학)
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.